Literature DB >> 8932851

Vascular endothelial lesion in patients undergoing bone marrow transplantation.

S Richard1, M Seigneur, A Blann, R Adams, M Renard, M Puntous, J M Boiron, J Amiral, J Reiffers, M Boisseau.   

Abstract

Changes in endothelial cell activity are likely to play a role in the thrombotic complications of bone marrow transplantation (BMT) such as the development of veno-occlusive disease. Accordingly, we measured established plasma endothelial cell markers von Willebrand factor (vWf), soluble thrombomodulin (sTM), soluble ICAM-1 (sICAM-1), and possible inducers of these molecules, TNF alpha and elastase, in the plasma of 25 patients, 1 week before as well as 1 and 3 weeks after BMT. Compared to healthy age and sex-matched controls, patients exhibited increased vWf and sTM. One week after transplantation, there were significant increases in vWf and sICAM-1, with a significant fall in elastases. Three weeks after the transplantation, sICAM-1 and, to a lesser extent, vWf increased still further, whereas elastases were unchanged. There were no significant changes in sTM and in TNF alpha through the serial study. Our data suggest that before conditioning, vascular endothelium is damaged by both injury and activation, as seen by the variations of vWf and sTM. After transplantation, the enhancement of this damage seems to be more specifically related to activation, since we observed a strong subsequent increase in vWf and markedly in sICAM-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932851

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions.

Authors:  Simona Pagliuca; David Michonneau; Flore Sicre de Fontbrune; Aurélien Sutra Del Galy; Aliénor Xhaard; Marie Robin; Régis Peffault de Latour; Gérard Socie
Journal:  Blood Adv       Date:  2019-08-13

2.  Improvement of high serum levels of biomarkers of endothelial injury after allogeneic hematopoietic SCT with pre-existing severe hepatitis using recombinant human soluble thrombomodulin.

Authors:  T Saito; Y Inoue; K Sato; Y Tsuruoka; R Shigefuku; H Ikeda; C Okuse; M Takahashi; I Miura
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

3.  Acquired storage-pool disorders occurring late after allogeneic bone marrow transplantation: partial activation of platelets in asymptomatic patients.

Authors:  C Sakashita; H Akiyama; Y Satoh; T Inoue; K Ohashi; S Mori; H Sakamaki; K Hiruma; M Endoh; N Akamatsu; K Tanoue
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

4.  Thrombotic microangiopathy in haematopoietic cell transplantation: an update.

Authors:  Evi Stavrou; Hillard M Lazarus
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-11-03       Impact factor: 2.576

Review 5.  Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation.

Authors:  Yan Man; Xiangmei Yao; Tonghua Yang; Yajie Wang
Journal:  Front Cell Dev Biol       Date:  2021-01-22

6.  Early Endothelial Activation in a Mouse Model of Graft vs Host Disease Following Chemotherapy.

Authors:  Melrine Pereira; Natasha Ting Lee; Jonathan Noonan; Abbey E H Willcox; Ilaria Calvello; Smitha Rose Georgy; Carly Selan; Joanne S Chia; Wayne Hauw; Xiaowei Wang; Karlheinz Peter; Simon C Robson; Harshal H Nandurkar; Maithili Sashindranath
Journal:  Front Immunol       Date:  2021-08-05       Impact factor: 7.561

Review 7.  Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?

Authors:  Giuseppe Lia; Luisa Giaccone; Sarah Leone; Benedetto Bruno
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.